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Abstract—A metabonomics approach based on high resolution 1H 
NMR spectroscopy was applied to investigate the metabolite 
fingerprints in urine and serum samples from db/db mice of 8 
weeks old, an animal model of type 2 diabetes mellitus (T2DM). 
Both NMR spectra and metabonomics results were discussed and 
the variations on related metabolic pathway were analyzed. The 
urinary excretions of diabetic mice have elevated levels of citrate, 
alanine, acetate, TMAO, hippurate, taurine, creatinine, 
succinate, pyruvate, glycine in addition to evident increase of 
glucose compared to the control ones. The metabolic variation in 
serum samples of db/db mice is marked by the increases of 
lactate, 3-hydroxybutyrate, glutamine, glutamate and choline and 
the decreases of leucine and valine. These results indicate that 
NMR-based metabonomics is an efficient approach for 
investigating the subtle metabolic alterations in urine and serum 
from diabetic mice and the findings of the characteristic 
metabolites would be helpful for early diagnosis and prevention 
of T2DM and its related complications. 
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I.  INTRODUCTION 
Type 2 diabetes mellitus (T2DM) has been considered as 
one of the main threats to human health in the 21st century [1]. 
It is characterized by the resistance of body tissues to the action 
of insulin on glucose uptake, resulting in prolonged 
hyperglycemia after intake of carbohydrates. T2DM is not an 
isolated disease entity but is a more general metabolic disorder 
(“Metabolic Syndrome”). Therefore detections of the 
endogenous metabolic variations in the whole body with the 
development and progression of T2DM will be highly 
valuable. 
Nuclear magnetic resonance (NMR) spectroscopy is one of 
the most powerful analytical tools that can provide a wealth of 
metabolite information of biological samples in relation to 
physiological and pathological disorders. The approach 
combining the NMR spectroscopic profiling of biological 
samples with multivariate statistical analysis is termed as 
NMR-based metabonomics [2]. It has been successfully 
applied in studying endogenous metabolic changes in biofluids 
such as urine, serum and saliva caused by diseases or drug 
toxicity [3]. Recently, a number of diabetes-related 
metabonomics studies have been reported on biofluids from 
animal models to human subjects [4,5]. Our preliminary results 
show that the 1H NMR metabonomics approach is capable of 
accessing characteristic small metabolites in human serum 
from diabetic patients [6]. 
In this work, NMR-based metabonomics was applied to 
investigate the urinary and haemal metabolic fingerprints of an 
animal model for T2DM –C57BLKS/J (db/db) mice relative to 
its control C56BLKS/J (db/m) mice at an early insulin 
resistance stage. The differences in global metabolite profiles 
in urine and serum samples as a result of physiological 
variations were identified and the underlying factors for the 
alterations were analyzed. This study validates the feasibility of 
metabonomics as a tool in characterizing and understanding the 
biochemical signatures of T2DM and insulin resistance, which 
would be helpful for early diagnosis and prevention of T2DM 
and its related complications. 
II. MATERIAL AND METHODS 
A. Animal Handling and Samples collection 
Five male db/db mice [7] were housed in plastic cages. Six 
male db/m mice were used as control. The animal room was 
under controlled condition (temperature, humidity, and a 
12-hour light-dark cycle) and the animals were provided with 
food and water at libitum. Animal care and experimental 
procedures were in accordance with the guidelines of Xiamen 
University Institutional Animal Care and Use Committee. 
Animals were weighted and blood glucose levels were 
measured using blood glucose meter from 4 to 8 weeks of age 
and urine and serum sample were collected by 8 weeks old. 
The urine samples were then centrifuged (3000rpm, 5min at 
4°C) to remove the particulate contaminants and were stored 
frozen at -80°C until measured, while the serum samples were 
centrifuged (3000rpm, 10min at 4°C) and stored frozen at 
-80°C until NMR experiments. 
B. Sample preparation and 1H NMR spectroscopy 
For both urine and serum samples, a volume of 400μl was 
mixed with 200μl phosphate buffer solution (0.2M 
Na2HPO4/0.2M NaH2PO4, pH7.4, 100% D2O) to minimize 
variations in pH. 0.3mM DSS (2,2-dimethyl-2-silapentane 
-5-sulfonic acid) was used as an internal reference standard at δ 
0.0. The mixture was piped into 5 mm NMR tubes. 
The 1H NMR spectra of the urine and serum samples were 
acquired on Varian NMR system 500 MHz spectrometer 
equipped with triple resonance probe. The probe temperature 
was set to 298K and the 90° pulse lengths were calibrated 
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individually for each sample. For the urine samples, a 
conventional presaturation pulse sequence for solvent 
suppression based on the 1D version of NOESY pulse 
sequence known as NOEPR (Nuclear Overhauser Effect 
spectroscopy with PResaturation; delay-90° -t1-90°-tm-90°- 
acquisition) was used [8], where the t1 delay was 4 μs, the 
mixing time tm was 100 ms, and a weak irradiation was applied 
to suppress water signal during recycle delay of 2 s and mixing 
time. For the serum samples, except for the same segment 
applied in urine, an additional Carr-Purcell-Meiboom-Gill 
(CPMG) spin-echo pulse train was incorporated with the 
relaxation time (2nτ) 100 ms and the echo time (τ) 250 μs. A 
total of 256 scans with a spectral width of 5 kHz were collected 
for all NMR spectra. All the signals were zero filled to 16k 
before regular Fourier transformation (FT). 
C. NMR data reduction and principal component analysis 
The collected NMR data were phased and baseline- 
corrected manually using the software MestRe-C 4.8 (http:// 
www.mestrec.com). The chemical shifts were referenced to the 
DSS at δ 0.0. Every spectrum was segmented into regions of 
0.04 ppm width in the range of 0.2 ~ 9.8 ppm. The region of 
4.6 ~ 6.0 ppm was excluded for urine spectra prior to principle 
component analysis (PCA) to remove the variations of both 
water and urea whereas only 4.6 ~5.0 ppm of water signal was 
excluded for serum spectra. The remaining spectral segments 
were scaled to total integrated area of each spectrum to account 
for the differences in concentration. PCA was carried out using 
the program written by ourselves. 
III. RESULTS AND DISCUSSIONS 
A. 1H NMR spectroscopy and principal component analysis 
of urine samples 
Two representative 1H NMR spectra of urine from diabetic 
and control mice are shown in Fig. 1. The main urinary 
metabolites were assigned according to literature [9]. The 
spectroscopic profilings of these two groups reveal obvious 
alterations in metabolite concentrations. The intensities of 
glucose signals are much stronger for db/db mice compared to 
the control ones, which are evaluated as a function of 
glycosuria commonly in T2DM subject. The levels of other 
small metabolites are also found significantly different and will 
be further identified by pattern recognition analysis. 
The score plot of PCA in Fig. 2(a) shows clear separation 
of the diabetic group from the control group, indicating the 
existence of discrepancy between these two classes. The data 
points of the diabetic group locate more dispersed than the 
control group owing to the larger differences in metabolic 
profiles of diabetes caused by complicated metabolic pathways 
of diabetes pathogenesis. The PC loading plot in Fig. 2(b) 
shows consistent characteristics with visual inspection of 
urinary 1H NMR spectra. It suggests that the separation is 
attributed to the NMR signals at δ 1.21, 1.48, 1.93, 2.38, 2.45, 
2.56, 3.06, 3.25, 3.30, 3.45, 3.57, 3.50-3.90 and 3.95 ppm, 
corresponding to butyrate, alanine, acetate, pyruvate, succinate, 
citrate, creatinine, arginine, TMAO, taurine, glycine, glucose 
and hippurate. 
Each characteristic metabolite mentioned above was 
examined carefully in every spectrum and the variations of 
metabolite concentrations were identified with the help of 
loading plot. The higher urinary excretion of citrate in diabetic 
subjects may be caused by increased citrate production in 




Figure 1. Representative 1H NMR spectra of urine from db/db (a) and 




Figure 2. PC score plot (a) and loading plot (b) (PC1 vs PC2) of 1H NMR 






due to glucose flow. The increase of alanine in db/db mice may 
be associated with a reduced insulin-mediated suppression of 
plasma amino acid concentrations and also be indicative of 
initial tubular damage. Elevated acetate has been proved to be 
the expression of overt renal insufficiency. Over-excretion of 
TMAO in diabetes may be linked to the hyperosmotic effect of 
glucose, or it may be indicative of papillary dysfunction [10]. 
The increased hippurate in diabetic mice reflects difference in 
gut microfloral populations. The elevation of taurine level in 
urine is considered as the most important biomarker for liver 
damage caused by abnormal glucose metabolism. A slightly 
higher excretion of creatinine is observed and thought to be 
related to early stage of renal dysfunction. Besides, glucose 
overflow which stimulates some glycolytic enzymatic activities 
in tubular cells may also account for the concentration changes 
in succinate and pyruvate. The change of glycine is not 
considered because of the possible overlapping of the peak 
with part of the intense glucose signals. 
B. 1H NMR spectroscopy and principal component analysis 
of serum samples 
Figure 3 shows the typical 1H NMR spectra of serum from 
diabetic and control mice with the main metabolites assigned 
[8]. As indicated in Section II, the CPMG technique was used 
to suppress the resonances from proteins and lipoproteins 
which partially obscure the sharp peaks from small molecules 
and reveal subtle biochemical information of samples. 
Inspection of the spectra indicates that the intensities of glucose 
signals from diabetic mice are slightly higher than those from 
the control ones, which is consistent with the blood glucose 
measurements using a blood glucose meter (data not shown). 
This is mainly due to mild hyperinsulinemia in db/db mice 
observed as early as 10 days after birth and sustained at least 
up to 10 weeks old. However, insulin resistance gradually 
develops as a result of the defects in insulin signaling so that 
the concentrations of metabolites such as valine, 
3-hydroxybutyrate and lactate etc. alter with the abnormal 
glucose and lipid metabolism. 
 
 
Figure 3. Representative 1H NMR spectra of serum from db/db (a) and 
db/m (b) mice (8 weeks old). 
The metabonomics differences of serum between the db/db 
and db/m groups are visible in Fig. 4(a), where the separation 
between two classes is obvious in spite of the individual 
differences in either class. The loading plot illuminates that this 
separation is attributed to the metabolites with δ 0.97 (leucine, 
valine), 1.20 (3-hydroxybutyrate), 1.33 (lactate), 2.36 
(glutamate), 2.41 (glutamine) and 3.21 (choline) ppm. 
 
 
Figure 4. PC score plot (a) and loading plot (b) (PC1 vs PC2) of 1H NMR 
spectra of serum from db/db (1-5, ) and db/m (6-11, ) mice. 
According to the 1H NMR spectra of serum, leucine and 
valine, known as the branched chain amino acid (BCAA), are 
depressed evidently in diabetic mice compared to the control 
mice. This is analogous to the decreased plasma BCAA found 
in humans and taken as one of the biomarkers for T2DM. 
Elevated plasma lactate concentration was ever reported in 
high-fat diet induced insulin resistance model mice [11] and 
may reflect the effect of hyperglycaemia on enhanced muscle 
lactate production. Significantly increased level of 
3-hydroxybutyrate which mainly came from elevated hepatic 
synthesis was found in the hyperketonemic diabetic animals. 
Glutamate and glutamine, intermediates and products of the 
tricarboxylic acid (TCA) cycle, may alter with the effect of 
3-hydroxybutyrate derived acetyl-CoA. Variation of choline 
was also recognized in horse blood of insulin resistance subject 
[12]. 
IV. CONCLUSIONS 
In this paper, high resolution 1H NMR spectroscopy 






to investigate the urine and serum of db/db mice – an animal 
model of type 2 diabetes mellitus. Clear differences in urine 
between 8-weeks-old diabetic (db/db) and control (db/m) mice 
were observed in both spectral and metabonomics traits. 
Except for the easily recognized sugar resonances, urine 
spectra from diabetic mice were highlighted by the increased 
level of citrate, alanine, acetate, TMAO, hippurate, taurine, 
creatinine, succinate, pyruvate, glycine. Furthermore, studies 
on the serum samples revealed the discrimination of T2DM 
mice from healthy controls in spite of the little variations in 
visual NMR spectral inspection. Compared to the control 
group, elevated serum lactate, 3-hydroxybutyrate, glutamine, 
glutamate and choline with declined leucine and valine were 
identified in the diabetic mice. These results indicate 
significant alterations in metabolic profiles of urine and serum 
at the insulin resistance stage of T2DM animals. Further 
investigations would be done to associate these results with the 
organ-specific metabolic information and clinical indicators of 
urine and blood tests, which may provide comprehensive 
knowledge of molecular biochemistry related to disease state.  
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